Miriam Mengoni

Magdeburg, ST, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Perioperative PD-1-inhibition in melanoma patients - a retrospective analysis from eight German skin cancer centers.

Perioperative PD-1-inhibition in melanoma patients - a retrospective analysis from eight German skin cancer centers.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: January 07, 2026

Title Not Found

Title Not Found

Journal: Dermatologie (Heidelberg, Germany)
Published: August 18, 2025

Outcome of systemic therapy in patients with advanced rare skin cancers: A retrospective multicenter DeCOG study of 209 patients.

Outcome of systemic therapy in patients with advanced rare skin cancers: A retrospective multicenter DeCOG study of 209 patients.

Journal: European journal of cancer (Oxford, England : 1990)
Published: August 03, 2025

From adjuvant to neoadjuvant treatment: New options in systemic therapy for melanoma

From adjuvant to neoadjuvant treatment: New options in systemic therapy for melanoma

Journal: Dermatologie (Heidelberg, Germany)
Published: April 14, 2025

Neoadjuvant treatment of melanoma

Neoadjuvant treatment of melanoma

Journal: Dermatologie (Heidelberg, Germany)
Published: April 07, 2025

Liver Metastases are Associated with a Short Post-Progression Survival in a Real-World Group of Patients with Melanoma Treated with Checkpoint Inhibitors.

Liver Metastases are Associated with a Short Post-Progression Survival in a Real-World Group of Patients with Melanoma Treated with Checkpoint Inhibitors.

Journal: Oncology and therapy
Published: October 03, 2024

Downregulation of MHC-I on Melanoma Cells and Decreased CD8+ T-Cell Infiltration Are Associated With Metastatic Spread and Resistance to Immunotherapy.

Downregulation of MHC-I on Melanoma Cells and Decreased CD8+ T-Cell Infiltration Are Associated With Metastatic Spread and Resistance to Immunotherapy.

Journal: Laboratory investigation; a journal of technical methods and pathology
Published: September 22, 2024

Switching PD-1 to BRAF + MEK inhibition improves recurrence-free survival in patients receiving a second course of adjuvant melanoma therapy.

Switching PD-1 to BRAF + MEK inhibition improves recurrence-free survival in patients receiving a second course of adjuvant melanoma therapy.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: August 07, 2024

Sarcopenia and immune-related toxicity in patients with malignant melanoma undergoing immune checkpoint inhibition

Sarcopenia and immune-related toxicity in patients with malignant melanoma undergoing immune checkpoint inhibition

Journal: Dermatologie (Heidelberg, Germany)
Published: July 18, 2024

MCAM Expression Facilitates Melanoma-Endothelial Interactions and Promotes Metastatic Disease Progression.

MCAM Expression Facilitates Melanoma-Endothelial Interactions and Promotes Metastatic Disease Progression.

Journal: Experimental dermatology
Published: June 22, 2024

Pegylated interferon-α2a in cutaneous T-cell lymphoma - a multicenter retrospective data analysis with 70 patients.

Pegylated interferon-α2a in cutaneous T-cell lymphoma - a multicenter retrospective data analysis with 70 patients.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: May 03, 2024

Low skeletal muscle mass predicts melanoma-specific survival in melanoma patients treated with adjuvant immune checkpoint blockade.

Low skeletal muscle mass predicts melanoma-specific survival in melanoma patients treated with adjuvant immune checkpoint blockade.

Journal: Journal of cancer research and clinical oncology
Published: March 31, 2024
Showing 1-12 of 29

Last Updated: 09/26/2026